analyzeportfolio
Nasdaq · Real Estate

Sabra Health Care REIT, Inc. (SBRA)

As-reported financials and SEC filings for Sabra Health Care REIT, Inc. The latest annual period is FY2025. The latest reported quarter is Q2 FY2026. Financial statements come straight from the company’s EDGAR filings; valuation figures such as P/E and market cap use market data.

About Sabra Health Care REIT, Inc.

Sabra Health Care REIT, Inc. is a real estate investment trust that owns and invests in healthcare-related properties in the United States and Canada. Its portfolio includes skilled nursing and transitional care facilities, senior housing communities, behavioral health facilities, and specialty hospitals, which it leases to third-party operators. The company serves healthcare providers by acquiring, financing, and managing real estate assets tailored to the needs of the healthcare industry.

Snapshot

Revenue
$774.6M
Revenue growth (YoY)
10.2%
Net income
$155.6M
Diluted EPS
$0.64
Gross margin
—
Operating margin
—
Net margin
20.1%
FCF margin
—
ROE
5.5%
net income / fiscal-year-end equity
P/E
75.8×
trailing when available, otherwise FY EPS
Market cap
$4.84B
Long-term debt / equity
0.90×
non-current term debt only

Fundamentals are from SEC filings for FY2025, the latest annual period (ended December 31, 2025). P/E and market cap are derived from stored market prices, last retrieved on a rolling basis and typically within the past week.

What changed at Sabra Health Care REIT

  • Revenue grew 10.2% to $775M in FY2025, in line with the 8.6% the year before.
  • Most recent quarter Q2 FY2026: revenue $129M, down 31.9% from Q2 FY2025.
  • Net income rose 22.8% to $156M in FY2025.

Computed from the as-reported figures in the statements below. A change we cannot state from filed figures is left out rather than estimated.

Peer comparison

Where Sabra Health Care REIT’s fundamentals sit among the 165 REITs. Each figure is ranked only against peers that report it, from lowest (left) to highest (right).

Net margin20.1%
64th percentile of 157
Revenue growth (YoY)+10.2%
79th percentile of 161
ROE5.5%
57th percentile of 142
P/E75.8×
85th percentile of 105
Long-term debt / equity0.90×
41st percentile of 100
Short interest7.83d
87th percentile of 154

Sabra Health Care REIT’s P/E of 75.8 ranks in the 85th percentile of the 105 peers with a meaningful P/E.

No reported insider purchases (code P) in the last 90 days; 1 insider sale totaling $4.2M. For context, about 15% of companies in the universe saw any reported insider purchase (code P) in the same window. Browse insider activity →

Percentiles describe where a figure sits among industry peers reporting it (100th = highest). They are position within a peer group, not a rating, and not investment advice. Short interest ranking uses days to cover from FINRA Consolidated Short Interest data; FINRA is the owner and source of that data, included at no additional charge.

Institutional ownership

Held by 1 of the superinvestors we track (plus 6 quant / multi-strat books), based on each investor’s most recent 13F; periods vary by investor (newest: Q2 2026).

Conviction investors
1
+6 quant / multi-strat
Initiated / added
2
0 new, 2 added
Reduced / exited
5
5 trimmed, 0 exited
Combined position
$140.4M
reported long value
InvestorAs ofPosition valueSharesChange
AQR Capital ManagementquantQ2 2026$39.0M2.0MAdded
Two Sigma InvestmentsquantQ2 2026$38.0M1.9MReduced
Point72 Asset ManagementquantQ2 2026$21.8M1.1MAdded
D. E. ShawquantQ2 2026$16.3M833.7KReduced
Millennium ManagementquantQ2 2026$14.6M746.2KReduced
Citadel AdvisorsquantQ2 2026$10.3M530.4KReduced
Gotham Asset ManagementQ2 2026$458,79723.5KReduced

From quarterly Form 13F filings, which can be up to 45 days delayed. Long US-listed positions only: excludes short positions, options, cash, bonds, and non-US holdings, so this is not a manager’s complete portfolio. Counts are of the investors we track, not all institutions. Not investment advice.

Recent insider activity

Non-derivative buys and sells (codes P/S) reported by officers, directors and 10% owners on SEC Form 4.

Buys (90d)
0
code P
Bought (90d)
—
code P value
Sells (90d)
1
$4.2M
Reported activity
Net selling
by $ value, 90d
Trade dateInsiderTypeSharesPriceValue
2026-09-08
filed 2026-09-09
Richard K. MatrosChair, CEO and PresidentSell200.0K$20.83$4.2M

Reported non-derivative purchases and sales (codes P/S), which may be open-market or private. Excludes option exercises, grants, and shares withheld for taxes. Dates shown are the trade date; a Form 4 can be filed days to years later. A sale can be routine (e.g. a pre-set 10b5-1 plan), so read individual transactions in context. From SEC Form 4. Not investment advice.

Short interest

Total shares sold short as of each twice-monthly FINRA settlement. Rising short interest means more investors are positioned against the stock; days to cover estimates how many trading days of average volume that position represents.

Shares short
19.9M
settled 2026-09-30
Change vs prior
-5.2%
vs previous settlement
Days to cover
7.83
at avg daily volume
Avg daily volume
2.5M
FINRA reported
SettlementShares shortChangeDays to cover
2026-09-3019.9M-5.2%7.83
2026-09-1521.0M+8.4%9.12
2026-08-3119.4M-21.5%10.34
2026-08-1424.7M+0.6%8.73
2026-07-3124.5M-1.8%7.41
2026-07-1525.0M-5.3%9.47
2026-06-3026.4M-0.6%6.13
2026-06-1526.5M-9.6%7.94

Source: FINRA Consolidated Short Interest. FINRA is the owner and source of the FINRA-supplied data, which is included at no additional charge for your own personal or professional use; republishing or redistributing it is not permitted. Settlement dates are shown; FINRA publishes each settlement about nine business days later, so the latest figure can be two to four weeks old. Not presented as a percentage of float. No FINRA endorsement of this product is implied. Not investment advice.

Income statement (as reported)

 FY2025FY2024FY2023FY2022FY2021
Revenue$774.6M$703.2M$647.5M$624.8M$569.5M
Gross profit—————
Operating income—————
Net income$155.6M$126.7M$13.8M$-77.6M$-113.3M
Diluted EPS$0.64$0.54$0.06$-0.34$-0.52

Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (tap or hover a figure to see how it was calculated or what was filed). Full details: where the numbers come from.

Balance sheet (as reported)

 FY2025FY2024FY2023FY2022FY2021
Cash and equivalents$71.5M$60.5M$41.3M$49.3M$112.0M
Current assets—————
Total assets$5.49B$5.30B$5.39B$5.75B$5.97B
Current liabilities—————
Long-term debt$2.53B$2.42B$2.41B$2.51B$2.39B
Total liabilities$2.67B$2.56B$2.58B$2.69B$2.59B
Total equity$2.82B$2.74B$2.80B$3.06B$3.38B

Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (tap or hover a figure to see how it was calculated or what was filed). Full details: where the numbers come from.

Cash flow (as reported)

 FY2025FY2024FY2023FY2022FY2021
Operating cash flow$348.6M$310.5M$300.6M$315.7M$356.4M
Capital expenditure—————
Free cash flow—————

Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (tap or hover a figure to see how it was calculated or what was filed). Full details: where the numbers come from.

Quarterly trend

QuarterRevenueRevenue YoYNet incomeDiluted EPS
Q2 FY2026$128.8M-31.9%$-25.2M$-0.10
Q1 FY2026$116.7M-36.4%$40.9M$0.16
Q4 FY202516.2%
Q3 FY2025$190.0M6.8%$22.5M$0.09
Q2 FY2025$189.2M7.4%$65.5M$0.27
Q1 FY2025$183.5M10.1%$40.3M$0.17
Q4 FY202411.6%
Q3 FY2024$178.0M10.1%$29.8M$0.13

Latest 8 quarters, from company XBRL filings on SEC EDGAR. A dotted underline marks a fourth-quarter figure we calculated from the full year and the first nine months. Revenue YoY is our calculation too: each quarter against the same quarter a year earlier.

Company facts

ExchangeNasdaq
SectorReal Estate
SIC industryReal Estate Investment Trusts
Latest annual periodFY2025 (ended December 31, 2025)
Latest reported quarterQ2 FY2026 (ended June 30, 2026)
Oldest indexed filing2016
SEC CIK1492298

Selected SEC filings

10-Q2026-08-03
View on EDGAR →
10-Q2026-04-29
View on EDGAR →
8-K2026-08-03
View on EDGAR →
8-K2026-07-21
View on EDGAR →
8-K2026-06-17
View on EDGAR →
8-K2026-05-28
View on EDGAR →

Largest reit peers

All reit stocks →All Real Estate companies →

Monitor SBRA

Get an alert when Sabra Health Care REIT files something material, see which superinvestors own it, and ask its filings a question with cited answers.

Monitor SBRA free

Includes one free filing-grounded research answer. Or check your whole portfolio, no account needed.

Data sourced from SEC EDGAR. Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only. Not investment advice.